These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 34530715)
1. The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer's Disease. Abd-Elrahman KS; Sarasija S; Ferguson SSG Curr Neuropharmacol; 2023; 21(2):273-283. PubMed ID: 34530715 [TBL] [Abstract][Full Text] [Related]
2. The Implication of Glial Metabotropic Glutamate Receptors in Alzheimer's Disease. de Lima IBQ; Ribeiro FM Curr Neuropharmacol; 2023; 21(2):164-182. PubMed ID: 34951388 [TBL] [Abstract][Full Text] [Related]
3. Metabotropic Glutamate Receptors in Alzheimer's Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future. Srivastava A; Das B; Yao AY; Yan R J Alzheimers Dis; 2020; 78(4):1345-1361. PubMed ID: 33325389 [TBL] [Abstract][Full Text] [Related]
4. Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals. Kim SH; Fraser PE; Westaway D; St George-Hyslop PH; Ehrlich ME; Gandy S J Neurosci; 2010 Mar; 30(11):3870-5. PubMed ID: 20237257 [TBL] [Abstract][Full Text] [Related]
6. Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes. Hamilton A; Zamponi GW; Ferguson SS Mol Brain; 2015 Mar; 8():18. PubMed ID: 25888324 [TBL] [Abstract][Full Text] [Related]
8. Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases. Li SH; Abd-Elrahman KS; Ferguson SSG Pharmacol Ther; 2022 Nov; 239():108275. PubMed ID: 36038019 [TBL] [Abstract][Full Text] [Related]
9. Deleterious Alteration of Glia in the Brain of Alzheimer's Disease. Kim E; Otgontenger U; Jamsranjav A; Kim SS Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932623 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of tau and Aβ-induced excitotoxicity. Pallo SP; DiMaio J; Cook A; Nilsson B; Johnson GVW Brain Res; 2016 Mar; 1634():119-131. PubMed ID: 26731336 [TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1/EAAT2 via different signaling pathways utilizing transcription factor NF-kappaB. Rodriguez-Kern A; Gegelashvili M; Schousboe A; Zhang J; Sung L; Gegelashvili G Neurochem Int; 2003; 43(4-5):363-70. PubMed ID: 12742080 [TBL] [Abstract][Full Text] [Related]
12. Targeting mGluR group III for the treatment of neurodegenerative diseases. Rabeh N; Hajjar B; Maraka JO; Sammanasunathan AF; Khan M; Alkhaaldi SMI; Mansour S; Almheiri RT; Hamdan H; Abd-Elrahman KS Biomed Pharmacother; 2023 Dec; 168():115733. PubMed ID: 37862967 [TBL] [Abstract][Full Text] [Related]
13. beta-Amyloid peptides impair PKC-dependent functions of metabotropic glutamate receptors in prefrontal cortical neurons. Tyszkiewicz JP; Yan Z J Neurophysiol; 2005 Jun; 93(6):3102-11. PubMed ID: 15659527 [TBL] [Abstract][Full Text] [Related]
14. Early Effects of the Soluble Amyloid β Castillo CA; Ballesteros-Yáñez I; León-Navarro DA; Albasanz JL; Martín M Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205261 [TBL] [Abstract][Full Text] [Related]
15. G protein-coupled receptor kinases are associated with Alzheimer's disease pathology. Guimarães TR; Swanson E; Kofler J; Thathiah A Neuropathol Appl Neurobiol; 2021 Dec; 47(7):942-957. PubMed ID: 34164834 [TBL] [Abstract][Full Text] [Related]
16. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective. Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998 [TBL] [Abstract][Full Text] [Related]
17. Metabotropic Glutamate Receptors Induce a Form of LTP Controlled by Translation and Arc Signaling in the Hippocampus. Wang H; Ardiles AO; Yang S; Tran T; Posada-Duque R; Valdivia G; Baek M; Chuang YA; Palacios AG; Gallagher M; Worley P; Kirkwood A J Neurosci; 2016 Feb; 36(5):1723-9. PubMed ID: 26843652 [TBL] [Abstract][Full Text] [Related]
18. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488 [TBL] [Abstract][Full Text] [Related]
19. [Abeta, tau and alpha-synuclein and glial cells]. Akiyama H Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Feb; 26(1):23-31. PubMed ID: 16637593 [TBL] [Abstract][Full Text] [Related]
20. The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease. Tsai VW; Scott HL; Lewis RJ; Dodd PR Neurotox Res; 2005; 7(1-2):125-41. PubMed ID: 15639804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]